1986Drug Development and Industrial PharmacyRequires access

Pharmacokinetic Interaction Between Dapsone and Rifampicin in Leprosy Patients

D. R. Krishna, A. V. N. Appa Rao, T. V. Ramanakar, M. C. Prabhakar

Open publisher page 6 citations

Abstract

Different pharmacokinetic parameters of dapsone and rifampicin following P. O. administration of dapsone 100 mg. alone, rifampicin 600 mg. alone and dapsone 100 mg. plus rifampicin 600 mg. in 7 cases of untreated patients of leprosy were investigated. The blood levels, half-life and AUC0-8 hrs. of dapsone were significantly reduced with simultaneous increase in plasma clearance when it was administered along with rifampicin. The pharmacokinetic behaviour of rifampicin was, however, not significantly affected in the presence of dapsone.

About this research paper

What this paper is about

Different pharmacokinetic parameters of dapsone and rifampicin following P. O. administration of dapsone 100 mg. alone, rifampicin 600 mg. alone and dapsone 100 mg. plus rifampicin 600 mg. in 7 cases of untreated patients of leprosy were investigated. The blood levels, half-life and AUC0-8 hrs. of dapsone were significantly reduced with simultaneous increase in plasma clearance when it was administered along with rifampicin. The pharmacokinetic behaviour of rifampicin was, however, not significantly affected in the presence of dapsone.

Why it matters

OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Different pharmacokinetic parameters of dapsone and rifampicin following P. O. administration of dapsone 100 mg. alone, rifampicin 600 mg. alone and dapsone 100 mg. plus rifampicin 600 mg. in 7 cases of untreated patients of leprosy were investigated. The blood levels, half-life and AUC0-8 hrs. of dapsone were significantly reduced with simultaneous increase in plasma clearance when it was administered along with rifampicin. The pharmacokinetic behaviour of rifampicin was, however, not significantly affected in the presence of dapsone.

Key concepts: Dapsone, Rifampicin, Pharmacokinetics, Leprosy, Pharmacology, Medicine, Immunology, Tuberculosis

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetic Interaction Between Dapsone and Rifampicin in Leprosy Patients — Research Paper | ScholarLens